|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/04 | |
| C07D 401/14 | |||
| C07D 413/14 | |||
| A61K 31/454 | |||
| A61K 31/4545 | |||
| A61K 31/506 | |||
| A61K 31/5377 | |||
| A61P 3/00 |
| (11) | Patento numeris | 2568812 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11781053.1 |
| Europos patento paraiškos padavimo data | 2011-05-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-03-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-10-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/035501 |
| Data | 2011-05-06 |
| (87) | Numeris | WO 2011/143057 |
| Data | 2011-11-17 |
| (30) | Numeris | Data | Šalis |
| 333451 P | 2010-05-11 | US |
| (72) |
HALE, Jeffrey, J., US
JIANG, Jinlong, US
SHEN, Dong-Ming, US
SHI, Zhi-Cai, US
SHU, Min, US
WU, Zhicai, US
YANG, Cangming, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS |
| NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS |